Lung cancer decisions — 2025

The Board granted service connection for the cause of the Veteran's death, finding that his lung cancer was related to his service-connected melanoma.

The Board granted an effective date of December 12, 2023, for a 50 percent evaluation of bipolar disorder and remanded the other issues for further development.

The Board remands the claim for a medical opinion regarding the etiology of the Veteran's liver, lung, brain, and bone cancers in relation to his service, including exposure to contaminated water at Camp Lejeune.

The Board granted service connection for the cause of the Veteran's death, determining that his fatal lung cancer was related to his military service.

The Board remands the claims for service connection for right and left lower extremity neuropathy, as well as lung cancer, due to a need for further evidence through VA examinations.

The Board remands the claim for an adequate medical opinion regarding the Veteran's cause of death, including lung cancer and cardio-pulmonary arrest, to address in-service toxic exposures.

The Board dismissed the veteran's appeals for service connection for various conditions due to a lack of jurisdiction over the claims.

The Board remands the claims for service connection for low back disability and lung cancer due to inadequate VA examinations.

The Board remands the claims for service connection for bilateral lung cancer, cancer of the tongue, and malignant tumor of tonsil and squamous cell carcinoma of the pharynx to obtain a new VA opinion.

The Board remands the claim for an opinion on whether the Veteran's metastatic non-small cell lung cancer was related to in-service asbestos exposure.

The Board denied service connection for residuals of testicular, prostate, and lung cancer as the conditions were not incurred during a period of ACDUTRA and are not related to any in-service injury or disease.

The Board remands the claim for service connection for lung cancer to obtain a new medical opinion addressing evidence of the Veteran's cessation of smoking and the gap between his last reported smoking and diagnosis.

The Board determined that the reduction in rating from 100 percent to 30 percent for service-connected lung cancer was proper, and restoration of the 100 percent rating is not warranted. The criteria for entitlement to special monthly compensation based on housebound status have also not been met.

The Board denied service connection for left upper extremity nerve damage, right upper extremity nerve damage, left lower extremity nerve damage, right lower extremity nerve damage, lung cancer, and emphysema.

The Board denied service connection for lung cancer and remanded the claims for sleep apnea and bilateral hearing loss for further development.

The Board granted service connection for lung cancer and cause of death, but remanded the claim for chronic obstructive pulmonary disease (COPD).

The Board remands the claim for service connection of the Veteran's cause of death, which was acute hypoxic respiratory failure due to stage IV lung cancer, to obtain a medical opinion regarding the relationship between the Veteran's service and his cause of death.

The Board denied service connection for lung cancer and brain cancer, as well as a total disability rating based on individual unemployability (TDIU) for accrued benefits purposes.

The Board denied service connection for lung cancer, finding no evidence that the Veteran's lung cancer was related to his in-service exposure to depleted uranium or any other in-service injury or disease.

The Board denied an initial rating in excess of 100 percent for lung cancer but granted special monthly compensation (SMC) based on the need for aid and attendance, effective December 7, 2022.